comparemela.com

Latest Breaking News On - Real world patient characteristics - Page 1 : comparemela.com

Real-World Patient Characteristics and Treatment Patterns Associated With Tucatinib Therapy in Patients With HER2+ Metastatic Breast Cancer

Jane Lowe Meisel, MD, presents data from a retrospective study investigating patient characteristics, treatment patterns, and clinical outcomes for tucatinib-based treatment in the real-world setting both overall and following fam-trastuzumab deruxtecan (T-DXd).

Jane lowe meiselReal world patient characteristicsPatients withMetastatic breastLowe meiselHer2 metastatic breast cancerTucatinib based treatmentFam trastuzumab deruxtecanT dxdHer2 targeted therapiesActive brain metasases

New Clinical and Real-World Data Support Use of DARZALEX®▼ (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma

Investigational daratumumab quadruple combination regimen shows responses in newly diagnosed, transplant-eligible patients with multiple myeloma in randomised Phase 2 GRIFFIN study1 Real-world.

United statesEdmond chan mbchJacob laubachImran khanAmerican society of clinical oncologyJanssen biotech incAmerican society of hematology annual meetingJerome lipper multiple myeloma centerJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonAmerican society of hematologyJanssen scientific affairsDana farber cancer instituteAmerican cancer societyNone of the janssen pharmaceutical companiesEuropean commission

Janssen: New Clinical and Real-World Data Support Use of DARZALEX? (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma

Investigational daratumumab quadruple combination regimen shows responses in newly diagnosed, transplant-eligible patients with multiple myeloma in randomised Phase 2 GRIFFIN study1 Real-world evidence

United statesNoah reymondEdmond chan mbchJacob laubachJessica mooreImran khanAmerican society of clinical oncologyJanssen biotech incAmerican society of hematology annual meetingJerome lipper multiple myeloma centerJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonAmerican society of hematologyJanssen scientific affairsDana farber cancer instituteAmerican cancer society

vimarsana © 2020. All Rights Reserved.